Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 3;8:720506. doi: 10.3389/fsurg.2021.720506

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Weng, Shen, Zhang, Fang, Xiao, Zhang, Fan, Huang, Wang, Huang, Wu, Zhang and Xu.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

(A) The change of each patient's KPS score after bevacizumab treatment. (B) Scatter plot of KPS scores of patients in cohort before and after bevacizumab treatment: the median KPS score of patients before bevacizumab treatment was 50, however, median KPS score increased to 90 after bevacizumab treatment. (C) Boxplot of imageology of patients in cohort before and after bevacizumab treatment. After bevacizumab treatment, the volume of nidus in Gadolinium and T2 sequence decreased by 44.7 and 74.2%, respectively.